Glycemic Control in Gestational Diabetes and Impact on Biomarkers in Women and Infants

Overview

Journal Pediatr Res

Specialties Biology
Pediatrics

Date 2023 Jan 17

PMID 36650305

Authors

Olivia J Hofer

Jane Alsweiler

Thach Tran

Caroline A Crowther

Affiliations

Soon will be listed here.

Abstract

Background: Gestational diabetes mellitus (GDM) is linked to the dysregulation of inflammatory markers in women with GDM compared to women without. It is unclear whether the intensity of glycemic control influences these biomarkers. We aimed to assess whether different glycemic targets for women with GDM and compliance influence maternal and infant biomarkers.

Methods: Maternity hospitals caring for women with GDM were randomized in the TARGET Trial to tight or less tight glycemic targets. Maternal blood was collected at study entry, 36 weeks' gestation, and 6 months postpartum, and cord plasma after birth. We assessed compliance to targets and concentrations of maternal serum and infant biomarkers.

Results: Eighty-two women and infants were included in the study. Concentrations of maternal and infant biomarkers did not differ between women assigned to tighter and less tight glycemic targets; however, concentrations were altered in maternal serum leptin and CRP and infant cord C-peptide, leptin, and IGF in women who complied with tighter targets.

Conclusions: Use of tighter glycemic targets in women with GDM does not change the concentrations of maternal and infant biomarkers compared to less tight targets. However, when compliance is achieved to tighter targets, maternal and infant biomarkers are altered.

Impact: The use of tighter glycemic targets in gestational diabetes does not result in changes to maternal or cord plasma biomarkers. However, for women who complied with tighter targets, maternal serum leptin and CRP and infant cord C-peptide, leptin and IGF were altered compared with women who complied with the use of the less tight targets. This article adds to the current evidence base regarding the impact of gestational diabetes on maternal and infant biomarkers. This article highlights the need for further research to assess enablers to meet the tighter target recommendations and to assess the impact on relevant biomarkers.

Citing Articles

Non-Pharmacological Management of Gestational Diabetes Mellitus with a High Fasting Glycemic Parameter: A Hospital-Based Study in Vietnam.

Nguyen H, Nguyen K, Nguyen P J Clin Med. 2024; 13(19).

PMID: 39407955 PMC: 11478153. DOI: 10.3390/jcm13195895.

Significance of Umbilical Cord Leptin Profile during Pregnancy in Gestational Diabetes Mellitus-A Systematic Review and Meta-Analysis.

Roca-Rodriguez M, Ramos-Garcia P, Lopez-Tinoco C, Aguilar-Diosdado M J Clin Med. 2023; 12(14).

PMID: 37510870 PMC: 10381212. DOI: 10.3390/jcm12144756.

References

Mantzoros C, Rifas-Shiman S, Williams C, Fargnoli J, Kelesidis T, Gillman M . Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study. Pediatrics. 2009; 123(2):682-9. PMC: 2761663. DOI: 10.1542/peds.2008-0343. View

Franklin B, Crisler Jr S, Shappley R, Armour M, McCommon D, Ferry Jr R . Real-time support of pediatric diabetes self-care by a transport team. Diabetes Care. 2013; 37(1):81-7. PMC: 3968448. DOI: 10.2337/dc13-1041. View

Martis R, Brown J, Crowther C . Views and Experiences of New Zealand Women with Gestational Diabetes in Achieving Glycaemic Control Targets: The Views Study. J Diabetes Res. 2017; 2017:2190812. PMC: 5684580. DOI: 10.1155/2017/2190812. View

Lekva T, Roland M, Michelsen A, Friis C, Aukrust P, Bollerslev J . Large Reduction in Adiponectin During Pregnancy Is Associated With Large-for-Gestational-Age Newborns. J Clin Endocrinol Metab. 2017; 102(7):2552-2559. DOI: 10.1210/jc.2017-00289. View

Fasshauer M, Bluher M, Stumvoll M . Adipokines in gestational diabetes. Lancet Diabetes Endocrinol. 2014; 2(6):488-99. DOI: 10.1016/S2213-8587(13)70176-1. View

Hussey M, Hughes J . Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2006; 28(2):182-91. DOI: 10.1016/j.cct.2006.05.007. View

Metzger B, Persson B, Lowe L, Dyer A, Cruickshank J, Deerochanawong C . Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics. 2010; 126(6):e1545-52. DOI: 10.1542/peds.2009-2257. View

Okereke N, Uvena-Celebrezze J, Amini S, Catalano P . The effect of gender and gestational diabetes mellitus on cord leptin concentration. Am J Obstet Gynecol. 2002; 187(3):798-803. DOI: 10.1067/mob.2002.125887. View

Dube M, Morisset A, Tchernof A, Weisnagel S . Cord blood C-peptide levels relate to the metabolic profile of women with and without gestational diabetes. Acta Obstet Gynecol Scand. 2012; 91(12):1469-73. DOI: 10.1111/aogs.12005. View

10.

Popova P, Vasilyeva L, Tkachuck A, Puzanov M, Golovkin A, Bolotko Y . A Randomised, Controlled Study of Different Glycaemic Targets during Gestational Diabetes Treatment: Effect on the Level of Adipokines in Cord Blood and ANGPTL4 Expression in Human Umbilical Vein Endothelial Cells. Int J Endocrinol. 2018; 2018:6481658. PMC: 5976949. DOI: 10.1155/2018/6481658. View

11.

Teague A, Fields D, Aston C, Short K, Lyons T, Chernausek S . Cord blood adipokines, neonatal anthropometrics and postnatal growth in offspring of Hispanic and Native American women with diabetes mellitus. Reprod Biol Endocrinol. 2015; 13:68. PMC: 4482040. DOI: 10.1186/s12958-015-0061-9. View

12.

Aramesh M, Dehdashtian M, Malekian A, ShahAli S, Shojaei K . Relation between fetal anthropometric parameters and cord blood adiponectin and high-sensitivity C-reactive protein in gestational diabetes mellitus. Arch Endocrinol Metab. 2017; 61(3):228-232. PMC: 10118795. DOI: 10.1590/2359-3997000000235. View

13.

Xu J, Zhao Y, Chen Y, Yuan X, Wang J, Zhu H . Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. ScientificWorldJournal. 2014; 2014:926932. PMC: 4151523. DOI: 10.1155/2014/926932. View

14.

Ryckman K, Spracklen C, Smith C, Robinson J, Saftlas A . Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG. 2015; 122(5):643-51. DOI: 10.1111/1471-0528.13261. View

15.

Karakosta P, Georgiou V, Fthenou E, Papadopoulou E, Roumeliotaki T, Margioris A . Maternal weight status, cord blood leptin and fetal growth: a prospective mother-child cohort study (Rhea study). Paediatr Perinat Epidemiol. 2013; 27(5):461-71. DOI: 10.1111/ppe.12074. View

16.

Lindsay R, Westgate J, Beattie J, Pattison N, Gamble G, Mildenhall L . Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol (Oxf). 2007; 66(3):322-8. DOI: 10.1111/j.1365-2265.2006.02719.x. View

17.

Kumari R, Singh H . The prevalence of elevated high-sensitivity C-reactive protein in normal pregnancy and gestational diabetes mellitus. J Family Med Prim Care. 2018; 6(2):259-264. PMC: 5749067. DOI: 10.4103/2249-4863.219995. View

18.

Miremberg H, Ben-Ari T, Betzer T, Raphaeli H, Gasnier R, Barda G . The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled trial. Am J Obstet Gynecol. 2018; 218(4):453.e1-453.e7. DOI: 10.1016/j.ajog.2018.01.044. View

19.

Crowther C, Samuel D, Hughes R, Tran T, Brown J, Alsweiler J . Tighter or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity: A stepped-wedge, cluster-randomised trial. PLoS Med. 2022; 19(9):e1004087. PMC: 9455881. DOI: 10.1371/journal.pmed.1004087. View

20.

Regnault N, Botton J, Heude B, Forhan A, Hankard R, Foliguet B . Higher cord C-peptide concentrations are associated with slower growth rate in the 1st year of life in girls but not in boys. Diabetes. 2011; 60(8):2152-9. PMC: 3142086. DOI: 10.2337/db10-1189. View